Bio-Rad Labs (BIO) Tops Q1 EPS by $1.54
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $277.87 -1.62%
EPS Growth %: -30.7%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -30.7%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $4.94, $1.54 better than the analyst estimate of $3.40. Revenue for the quarter came in at $700 million versus the consensus estimate of $675.1 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Playboy to buy back 16.6M shares from Fortress at $1.05 each
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
